SCHEMBL6567879

SCHEMBL6567879

COC(=O)c1cc(NC(=O)Nc2ccccc2)ccc1OCCOC(C)=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.57
MEN1 O00255 3/20 0.57
LMNA P02545 3/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
HIF1A Q16665 4/20 0.49
NPSR1 Q6W5P4 2/20 0.48
MAPT P10636 2/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46
S1PR1 P21453 1/20 0.46
CASR P41180 1/20 0.45
PTPN1 P18031 3/20 0.45
PTPN2 P17706 2/20 0.45
PTPN6 P29350 2/20 0.45
PTPN11 Q06124 2/20 0.45
ESRRA P11474 2/20 0.44
MCHR1 Q99705 1/20 0.44
PTPRF P10586 1/20 0.44
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6564526 0.87 MEN1 (0.58) KMT2AMEN1LMNASMN1; SMN2HIF1A
SCHEMBL6565674 0.86 KMT2A (0.57) KMT2AMEN1LMNASMN1; SMN2HIF1A
SCHEMBL6566692 0.82 MEN1 (0.61) KMT2AMEN1LMNASMN1; SMN2HIF1A
SCHEMBL6567903 0.82 MEN1 (0.61) KMT2AMEN1LMNASMN1; SMN2HIF1A
SCHEMBL6566721 0.81 KMT2A (0.57) KMT2AMEN1LMNASMN1; SMN2HIF1A
SCHEMBL6568089 0.80 MEN1 (0.58) KMT2AMEN1LMNASMN1; SMN2HIF1A
SCHEMBL6566664 0.79 MEN1 (0.57) KMT2AMEN1LMNASMN1; SMN2HIF1A
SCHEMBL6564697 0.78 MEN1 (0.56) KMT2AMEN1LMNASMN1; SMN2HIF1A
SCHEMBL6566726 0.78 MEN1 (0.56) KMT2AMEN1LMNASMN1; SMN2HIF1A
SCHEMBL6566900 0.78 MEN1 (0.56) KMT2AMEN1LMNASMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 KMT2A 3137/4885MEN1 4143/4885LMNA 4043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.